Sanofi-Aventis

Erzsebet Walcz

Lajos T Nagy

Sandor Batori

Laszlo Balazs

Zoltan Kapui

Peter Aranyi

Endre Mikus

Geza Timari

Kinga Boer

Katalin Urban-Szabo

Tibor Szabo

Maria Balogh

Judit Vargane Szeredi

Katalin Gerber

Judit Bence

Felix Hajdu

Katalin Urban Szabo

The present invention relates to adenosine Areceptor ligands of the general formula (I), within those preferably antagonists, as well as their salts, solvates and isomers, and the pharmaceutical compositions containing them, to the use of the compounds of the general formula (I), as well as their salts, solvates and isomers, to the preparation of the compounds of the general formula (I) and their salts, solvates and isomers, furthermore to the new intermediates of the general formulae (II) and to the preparation thereof.

Triazolo-quinolin derivatives useful as adenosine receptor ligands

This invention is directed to a compound of formula (I), wherein R, R, R, R, R, R, R, R, R, R, X, Z, m, n, o, p and r are as defined herein, its preparation, pharmaceutical composition and use as an adenosine Areceptor ligand preferably an antagonist.

Imidazoquinoline derivatives as adenosine A3 receptor ligands

The present invention relates to adenosine A3? receptor ligands of the general formula (I), within those preferably antagonists, as well as their salts, solvates and isomers, and the pharmaceutical compositions containing them, to the use of the compounds of the general formula (I), as well as their salts, solvates and isomers, to the preparation of the compounds of the general formula (I) and theirs salts, solvates and isomers, furthermore to the new intermediates of the general formulae (II) and to the preparation thereof.

Growing community of inventors

Budapest, Hungary

Erzsebet Walcz